WHAT THEY ARE SAYING: BIOGEN’S “SIMPLY UNACCEPTABLE” ADUCANUMAB PRICING HIGHLIGHTS URGENCY FOR RX SOLUTIONS
Broad-based Opposition to Egregious Launch Price on Drug With Unproven… Read More
© 2026 CSRXP- All Rights Reserved
CSRXP: FDA APPROVAL AND SUBSEQUENT BIOGEN PRICING OF ADUCANUMAB DEMAND RETROSPECTION, REFORM
Troubling for Public Health Institution to Depart from Established Norms to… Read More
ICYMI: BIG PHARMA’S FASTER-THAN-INFLATION PRICE HIKES COSTING MEDICARE BILLIONS OF DOLLARS
AARP Study Finds Brand Name Drug Companies Increased Prices Above Rate of… Read More
SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
For far too long Big Pharma has used the excuse that research and development… Read More
CSRXP AD BLITZ: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE NOW
Campaign Calls for Promises Made to the American People to Lower Prescription… Read More
CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET
Time for the Administration and Congress to Convert Promises Made Into… Read More
THEY SAID IT! ABBVIE CEO BRAGS ON ABILITY TO HIKE PRICES IN U.S., ADMITS COMPETITION WORKS AND CONFIRMS BIG PHARMA PATENT GAMES DESIGNED FOR “PRICING POWER”
House Oversight Lawmakers Commit to Bipartisan Action to Hold Big Pharma… Read More
DOSE OF REALITY: HUMIRA: A CASE STUDY IN BIG PHARMA GREED
AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive… Read More
THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS
Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE & ASTRAZENECA
Drug Companies Top Wall Street Expectations; Pfizer Raises Guidance Based On… Read More
BIG PHARMA EARNINGS WATCH: SANOFI, MERCK, BRISTOL-MYERS SQUIBB, AMGEN & GLAXOSMITHKLINE
Brand Name Drug Makers Boosting Profits, Sales After Engaging In Pandemic… Read More
BIG PHARMA WATCH: GAO REPORT FINDS U.S. CONSUMERS PAY DOUBLE TO QUADRUPLE FOR RX DRUGS
Study Finds Americans Face Much Higher Drug Prices Than Patients In Other… Read More